Hillenbrand — Q2 2025 Earnings Presentation
22 slides from Hillenbrand's earnings presentation, Apr 30, 2025
Slide 1: Second Quarter FY 2025 Earnings Call Presentation
Second Quarter FY 2025 Earnings Call Presentation April 30, 2025
Slide 2: Disclosure Regarding Forward-Looking Statements
Disclosure Regarding Forward-Looking Statements Throughout this earnings presentation, we make a number of “forward-looking statements,” including statements that are within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as a
Slide 3: Significant Transformation Over the Last Three Years
Significant Transformation Over the Last Three Years Completed Completed Completed Completed Completed Completed Completed June 2022 September 2022 October 2022 December 2022 February 2023 September 2023 March 2025 New Leadership FPM and 2 Food and Performance Materials Company Purpose A specialist
Slide 4: Q2 Overview
Q2 Overview Q2 2025 Key Metrics1,2 • Completed majority sale of Milacron, positioning Hillenbrand toward higher-margin, higher-growth, less cyclical portfolio; strengthens -9% $785M $716M foundation for profitable growth once macro conditions improve Revenue • Disciplined execution drives Q2 perform
Slide 5: FY25 2H Direct Tariff Impact
FY25 2H Direct Tariff Impact Focus Toward Short-, Mid-, and Long-Term Actions • Supply Chain Optimization: Leveraging global manufacturing footprint China 145% Tariff: ~$7M with regionalized production to reduce cross-border tariff exposure; evaluating additional footprint opportunities; buy where y
Slide 6: Q2 Consolidated Performance
Q2 Consolidated Performance1 Revenue Adj. EBITDA2 Adj. EPS2 Operating Cash Flow -9% -19% -21% -$2M $785 $0.76 $716 $123 $0.60 $3 $99 $1 Q2 2024 Q2 2025 Q2 2024 Q2 2025 Q2 2024 Q2 2025 Q2 2024 Q2 2025 Performance Highlights1,2 Business Update2 • Revenue of $716 million decreased 9%, primarily driven
Slide 7: Segment Performance: Advanced Process Solutions
Segment Performance: Advanced Process Solutions Revenue Adj. EBITDA1 Adj. EBITDA Margin1 -12% -22% -200 bps $559 $494 18.0% $101 16.0% $79 Q2 2024 Q2 2025 Q2 2024 Q2 2025 Q2 2024 Q2 2025 Performance Highlights1 Business Update • Revenue of $494 million decreased 12%, primarily driven by lower capita
Slide 8: Segment Performance: Molding Technology Solutions
Segment Performance: Molding Technology Solutions Revenue Adj. EBITDA1 Adj. EBITDA Margin1 -2% -4% -40 bps $226 $222 $34 14.9% 14.5% $32 Q2 2024 Q2 2025 Q2 2024 Q2 2025 Q2 2024 Q2 2025 Performance Highlights1 Business Update • Revenue of $222 million decreased 2%, primarily driven by unfavorable for
Slide 9: Capital Deployment / Capital Position
Capital Deployment / Capital Position Maintain Appropriate Leverage Liquidity3 ($M) Debt Maturity Schedule4 ($M) • Desired net leverage1 range of 1.7x – 2.7x • Top priority for cash flow is reducing leverage to return to preferred range $700 • Net proceeds after tax of ~$265M from Milacron transacti
Slide 10: FY25 Updated Guidance
FY25 Updated Guidance – Lower Order Intake Stemming from Heightened Macroeconomic Uncertainty and Increased Direct Tariff Costs Drive Change in Outlook Updated Guidance Previous Guidance Advanced Molding Advanced Molding Hillenbrand Process Technology Hillenbrand Process Technology Solutions Solutio
Slide 11: FY25 Key Guidance Assumptions (at midpoint)
FY25 Key Guidance Assumptions (at midpoint) APS • Orders declining from FY24, no improvement in 2H vs 1H • Top line decline due to lower starting backlog • Decline in aftermarket volumes from FY24 due to fewer spare parts packages as a result of lower capital orders • Partially mitigating decrementa
Slide 12: Q&A
Q&A HILLENBRAND 12
Slide 13: Replay Information
Replay Information • Dial-in for US and Canada: +1 (877) 407-8012 • Dial-in for International: +1 (412) 902-1013 • Conference ID: 13752558 • Date/Time: Available until midnight ET, Wednesday, May 14, 2025 • Log-on to: http://ir.hillenbrand.com 13
Slide 14: Appendix
Appendix HILLENBRAND
Slide 15: Disclosure Regarding Non-GAAP Financial Measures
Disclosure Regarding Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with United States generally accepted accounting principles (GAAP), this earnings presentation also contains non-GAAP operating performance measures. These non-GAAP financial measures are re
Slide 16: Reconciliation of Adjusted EBITDA to Consolidated Net (Loss) Income
Reconciliation of Adjusted EBITDA to Consolidated Net (Loss) Income Three Months Ended March 31, Six Months Ended March 31, (in millions) 2025 2024 2025 2024 Adjusted EBITDA: Advanced Process Solutions $ 78.9 $ 100.8 $ 161.6 $ 196.8 Molding Technology Solutions 32.2 33.6 59.6 65.7 Corporate (12.3) (
Slide 17: Reconciliation of (Loss) Income to Adjusted Net Income & Diluted EPS to Adjusted Diluted EPS
Reconciliation of (Loss) Income to Adjusted Net Income & Diluted EPS to Adjusted Diluted EPS for Continuing Operations Three Months Ended March 31, Six Months Ended March 31, (in millions, except per share data) 2025 2024 2025 2024 (Loss) income from continuing operations $ (38.6) $ 8.6 $ (29.7) $ 2
Slide 18: Reconciliation of Consolidated Net (Loss) Income to Adjusted EBITDA
Reconciliation of Consolidated Net (Loss) Income to Adjusted EBITDA Three Months Ended March 31, Six Months Ended March 31, (in millions) 2025 2024 2025 2024 Consolidated net (loss) income $ (38.6) $ 8.6 $ (29.7) $ 27.8 Interest expense, net 23.2 30.8 48.3 60.6 Income tax (benefit) expense (5.7) 4.2
Slide 19: Reconciliation of Reported Backlog to Organic Backlog
Reconciliation of Reported Backlog to Organic Backlog March 31, March 31, (in millions) 2025 2024 Advanced Process Solutions backlog $ 1,594.9 $ 1,877.1 Foreign currency impact 1.6 - Advanced Process Solutions organic backlog 1,596.5 1,877.1 Molding Technology Solutions backlog 54.7 229.8 Less: Dive
Slide 20: Ratio of Net Debt to Pro Forma Adjusted EBITDA for the trailing twelve months
Ratio of Net Debt to Pro Forma Adjusted EBITDA for the trailing twelve months ended March 31, (in millions) 2025 Current portion of long-term debt $ 23.8 Long-term debt 1,892.9 Total debt 1,916.7 Less: Cash and cash equivalents 458.4 Net debt $ 1,458.3 Pro forma adjusted EBITDA for the trailing twel
Slide 21: Reconciliation of Net Cash Flows
Reconciliation of Net Cash Flows Six Months Ended March 31, (in millions) 2025 2024 Cash flows (used in) provided by: Operating activities from continuing operations $ (10.0) $ (20.8) Investing activities from continuing operations 90.8 (27.9) Financing activities from continuing operations 188.4 46
Slide 22: Reconciliation of GAAP Effective Tax Rate to Adjusted Effective Tax Rate
Reconciliation of GAAP Effective Tax Rate to Adjusted Effective Tax Rate 22